This is a preview of subscription content, log in via an institution to check access.
Reference
Kitagawa Y, et al. Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: A single cancer center retrospective study. Cancer Management and Research 11: 5757-5764, 25 Jun 2019. Available from: URL: http://doi.org/10.2147/CMAR.S201048 - Japan
Rights and permissions
About this article
Cite this article
Amrubicin. Reactions Weekly 1768, 39 (2019). https://doi.org/10.1007/s40278-019-66724-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-66724-8